In the US, InGeneron’s Transpose® Ultra System is for investigational use only. We offer a portfolio of products for the preparation, characterization, and administration of adipose-derived regenerative cells including mesenchymal stem cells. Our product line focuses on point of care, providing for preparation and an autologous therapeutic administration of cells within a single procedure without the need for cell expansion.
The Transpose® Ultra System consists of the Transpose® Ultra Tissue Processing Unit plus a number of other disposable components, including the pharmaceutical-grade MatraseTM enzyme blend and single-use disposables that enable the isolation of regenerative cells from a patient’s own adipose tissue. In the US, InGeneron’s Transpose® Ultra System is for investigational use only. In Europe, the Transpose® Ultra System uses clinical-grade components and is registered under the CE Mark for human use upon prescription by a physician in Europe.





Contact us for a product demo at [email protected].